Impact of SARS-CoV-2 Vaccines on Covid-19 Incidence and Mortality in the United States
Abstract
Background
Despite safe and effective vaccines to prevent Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infections and disease, a substantial minority of the US remains resistant to getting vaccinated. It is imperative to know if expanding vaccination rates could reduce community-wide Coronavirus 2019 (COVID-19) disease, not just among those vaccinated.
Methods
Negative binomial models were used to estimate associations between U.S. county-level vaccination rates and county-wide COVID-19 incidence and mortality between April 23 rd and September 30 th , 2021. A two-week lag and a four-week lag were introduced to assess vaccination rate impact on incidence and mortality, respectively. Stratified analyses were performed for county vaccination rates 40%, and before and after Delta became the dominant variant.
Findings
Among 3,070 counties, each percentage increase in population vaccination rates reduced county-wide COVID-19 incidence by 0·9% (relative risk (RR) 0. 9910 (95% CI: 0·9869, 0·9952)) and mortality by 1·9% (RR 0·9807 (95% CI: 0·9745, 0·9823)). Among counties with vaccination coverage >40%, each percentage increase in vaccination rates reduced COVID-19 disease by 1·5%, RR 0·9850 (95% CI: 0·9793, 0·9952) and mortality by 2·7% (RR 0·9727 (95% CI: 0·9632, 0·9823)). These associations were not observed among counties with <40% vaccination rates. Increasing vaccination rates from 40% to 80% would have reduced COVID-19 cases by 45·4% (RR 0·5458 (95% CI: 0·4335, 0·6873)) and deaths by 67·0% (RR 0·3305 (95% CI: 0·2230, 0·4898)). An estimated 5,989,952 COVID-19 cases could have been prevented and 127,596 lives saved had US population vaccination rates increased from 40% to 80%.
Interpretations
Increasing U.S. SARS-CoV-2 vaccination rates results in population-wide reductions in COVID-19 incidence and mortality. Furthermore, increasing vaccination rates above 40% has protective effects among non-vaccinated persons. Given ongoing vaccine hesitancy in the U.S., increasing vaccination rates could better protect the entire community and potentially reach herd immunity.
Funding
National Cancer Institute
Related articles
Related articles are currently not available for this article.